84 related articles for article (PubMed ID: 21716316)
1. CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer.
Ågesen TH; Berg M; Clancy T; Thiis-Evensen E; Cekaite L; Lind GE; Nesland JM; Bakka A; Mala T; Hauss HJ; Fetveit T; Vatn MH; Hovig E; Nesbakken A; Lothe RA; Skotheim RI
Genes Immun; 2011 Dec; 12(8):653-62. PubMed ID: 21716316
[TBL] [Abstract][Full Text] [Related]
2. Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.
Berg M; Agesen TH; Thiis-Evensen E; ; Merok MA; Teixeira MR; Vatn MH; Nesbakken A; Skotheim RI; Lothe RA
Mol Cancer; 2010 May; 9():100. PubMed ID: 20459617
[TBL] [Abstract][Full Text] [Related]
3. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.
Laiho P; Kokko A; Vanharanta S; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Karttunen TJ; Tuppurainen K; Davalos V; Schwartz S; Arango D; Mäkinen MJ; Aaltonen LA
Oncogene; 2007 Jan; 26(2):312-20. PubMed ID: 16819509
[TBL] [Abstract][Full Text] [Related]
4. A Distinct Innate Immune Signature of Early Onset Colorectal Cancer.
Gardner IH; Siddharthan R; Watson K; Dewey E; Ruhl R; Khou S; Guan X; Xia Z; Tsikitis VL; Anand S
Immunohorizons; 2021 Jun; 5(6):489-499. PubMed ID: 34162701
[TBL] [Abstract][Full Text] [Related]
5. A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis.
Hong Y; Ho KS; Eu KW; Cheah PY
Clin Cancer Res; 2007 Feb; 13(4):1107-14. PubMed ID: 17317818
[TBL] [Abstract][Full Text] [Related]
6. SVM-T-RFE: a novel gene selection algorithm for identifying metastasis-related genes in colorectal cancer using gene expression profiles.
Li X; Peng S; Chen J; Lü B; Zhang H; Lai M
Biochem Biophys Res Commun; 2012 Mar; 419(2):148-53. PubMed ID: 22306013
[TBL] [Abstract][Full Text] [Related]
7. Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences.
Pilozzi E; Maresca C; Duranti E; Giustiniani MC; Catalanotto C; Lucarelli M; Cogoni C; Ferri M; Ruco L; Zardo G
Am J Clin Pathol; 2015 Mar; 143(3):374-84. PubMed ID: 25696795
[TBL] [Abstract][Full Text] [Related]
8. The increasing incidence of young-onset colorectal cancer: a call to action.
Ahnen DJ; Wade SW; Jones WF; Sifri R; Mendoza Silveiras J; Greenamyer J; Guiffre S; Axilbund J; Spiegel A; You YN
Mayo Clin Proc; 2014 Feb; 89(2):216-24. PubMed ID: 24393412
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility genetic variants associated with early-onset colorectal cancer.
Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.
Hampel H; Stephens JA; Pukkala E; Sankila R; Aaltonen LA; Mecklin JP; de la Chapelle A
Gastroenterology; 2005 Aug; 129(2):415-21. PubMed ID: 16083698
[TBL] [Abstract][Full Text] [Related]
12. Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review.
Young JP; Win AK; Rosty C; Flight I; Roder D; Young GP; Frank O; Suthers GK; Hewett PJ; Ruszkiewicz A; Hauben E; Adelstein BA; Parry S; Townsend A; Hardingham JE; Price TJ
J Gastroenterol Hepatol; 2015 Jan; 30(1):6-13. PubMed ID: 25251195
[TBL] [Abstract][Full Text] [Related]
13. Age at onset should be a major criterion for subclassification of colorectal cancer.
Perea J; Rueda D; Canal A; Rodríguez Y; Álvaro E; Osorio I; Alegre C; Rivera B; Martínez J; Benítez J; Urioste M
J Mol Diagn; 2014 Jan; 16(1):116-26. PubMed ID: 24184227
[TBL] [Abstract][Full Text] [Related]
14. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.
Katlinski KV; Gui J; Katlinskaya YV; Ortiz A; Chakraborty R; Bhattacharya S; Carbone CJ; Beiting DP; Girondo MA; Peck AR; Puré E; Chatterji P; Rustgi AK; Diehl JA; Koumenis C; Rui H; Fuchs SY
Cancer Cell; 2017 Feb; 31(2):194-207. PubMed ID: 28196594
[TBL] [Abstract][Full Text] [Related]
17. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
Zhang YZ; Sheng JQ; Li SR; Wu ZT
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
[TBL] [Abstract][Full Text] [Related]
18. Systematic search for rare variants in Finnish early-onset colorectal cancer patients.
Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Järvinen H; Mecklin JP; Böhm J; Kilpivaara O; Pitkänen E; Palin K; Vahteristo P; Tuupanen S; Aaltonen LA
Cancer Genet; 2015; 208(1-2):35-40. PubMed ID: 25749350
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
